Hyperbaric oxygen therapy on aging diseases
1 Medical Study Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
2 Division of Pharmacology, Department of Anatomy, Histology and Pharmacology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
3 Department of Health Science, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Review Article
World Journal of Advanced Research and Reviews, 2024, 24(03), 1281–1286
Publication history:
Received on 02 November 2024; revised on 11 December 2024; accepted on 13 December 2024
Abstract:
Aging happens in all creatures and is usually measured based on chronological age. Someone over 65 years of age is often referred to as an elderly person. This is also the age when biological degeneration usually occurs causing a decline in performance and having a major risk factor for aging diseases. Hyperbaric oxygen therapy (HBOT) is a therapeutic approach based on exposure to concentrations of pure oxygen (O2) and increased atmospheric pressure that could be performed based on the patient’s conditions. HBOT has an approved indication and also some contraindication that needs to be looked up to. HBOT has proven to have positive effects on some aging diseases such as increasing VO2Max, decreasing neuronal degeneration in Alzheimers disease, and accelerating collagen synthesis in osteomyelitis. Literature reviews on HBOT's effects on elderly people who suffer from aging diseases are still quite limited. Although some cases of HBOT are still facing pros and contras on its effects, this literature review is expected to be useful in conducting HBOT effects on aging diseases. However, further research is needed related to HBOT on enhancing quality of life for elderly people who suffer from aging diseases.
Keywords:
HBOT; Aging diseases; Elderly people; Alzheimer; Osteomyelitis
Full text article in PDF:
Copyright information:
Copyright © 2024 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0